Please provide your email address to receive an email when new articles are posted on . Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer ...

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO VISION ® Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, ...

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...

The revolutionary ORTHO VISION® analyzer is a highly interactive, fully automated blood bank analyzer engineered for the specific needs of transfusion medicine. Utilizing innovative ID-MTS ® gel ...

RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that ORTHO Sera, a suite of extended antigen phenotyping, has been cleared by the US Food and Drug Administration for use ...

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...